Spots Global Cancer Trial Database for CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
Official Title: A Phase II Study of Concurrent Chemoradiotherapy With Twice Weekly Paclitaxel and Cisplatin (Twice Weekly TP) Followed by Surgery for Locally Advanced Esophageal Cancer
Study ID: NCT00154804
Conditions
Interventions
Study Description
Brief Summary: CCRT with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.
Detailed Description: The purpose of this study is to find out the clinical and pathological response rates of pre-operative concurrent chemoradiotherapy (CCRT) with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Oncology, Nationa Taiwan University Hospital, Taipei, , Taiwan
Contact Details
Name: Chih-Hung Hsu, M.D.,Ph.D.
Affiliation: Department of Oncology, National Taiwan University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Ann-Lii Cheng, M.D.,Ph.D
Affiliation: Department of Oncology, National Taiwan University Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
